Metropolitan Life Insurance Company (MetLife)’s Visteon VC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,449
| Closed | -$170K | – | 2029 |
|
|
2024
Q1 | $170K | Sell |
1,449
-116
| -7% | -$13.5K | 0.01% | 783 |
|
|
2023
Q4 | $195K | Sell |
1,565
-54
| -3% | -$6.68K | 0.01% | 738 |
|
|
2023
Q3 | $224K | Buy |
1,619
+93
| +6% | +$13.4K | 0.01% | 628 |
|
|
2023
Q2 | $219K | Buy |
1,526
+22
| +1% | +$3.14K | 0.01% | 642 |
|
|
2023
Q1 | $236K | Sell |
1,504
-208
| -12% | -$32.2K | 0.01% | 614 |
|
|
2022
Q4 | $224K | Buy |
1,712
+85
| +5% | +$11.3K | 0.01% | 669 |
|
|
2022
Q3 | $173K | Sell |
1,627
-91
| -5% | -$10.9K | 0.01% | 731 |
|
|
2022
Q2 | $178K | Hold |
1,718
| – | – | 0.01% | 743 |
|
|
2022
Q1 | $187K | Sell |
1,718
-9,953
| -85% | -$1.08M | 0.01% | 846 |
|
|
2021
Q4 | $1.3M | Sell |
11,671
-241
| -2% | -$26.8K | 0.02% | 796 |
|
|
2021
Q3 | $1.12M | Sell |
11,912
-673
| -5% | -$72.6K | 0.02% | 866 |
|
|
2021
Q2 | $1.52M | Buy |
12,585
+486
| +4% | +$58.4K | 0.02% | 700 |
|
|
2021
Q1 | $1.48M | Sell |
12,099
-25
| -0.2% | -$3.28K | 0.02% | 705 |
|
|
2020
Q4 | $1.52M | Sell |
12,124
-814
| -6% | -$85.8K | 0.02% | 614 |
|
|
2020
Q3 | $896K | Sell |
12,938
-263
| -2% | -$19.4K | 0.02% | 807 |
|
|
2020
Q2 | $904K | Sell |
13,201
-2,144
| -14% | -$135K | 0.02% | 795 |
|
|
2020
Q1 | $736K | Sell |
15,345
-219
| -1% | -$15.9K | 0.02% | 833 |
|
|
2019
Q4 | $1.35M | Sell |
15,564
-765
| -5% | -$68.2K | 0.02% | 745 |
|
|
2019
Q3 | $1.35M | Buy |
16,329
+5,322
| +48% | +$355K | 0.02% | 701 |
|
|
2019
Q2 | $645K | Buy |
11,007
+1,985
| +22% | +$121K | 0.01% | 1143 |
|
|
2019
Q1 | $608K | Sell |
9,022
-209
| -2% | -$15.7K | 0.01% | 1168 |
|
|
2018
Q4 | $556K | Sell |
9,231
-139
| -1% | -$10.5K | 0.01% | 1128 |
|
|
2018
Q3 | $870K | Buy |
9,370
+7,608
| +432% | +$880K | 0.01% | 1009 |
|
|
2018
Q2 | $228K | Sell |
1,762
-573
| -25% | -$71.6K | ﹤0.01% | 1860 |
|
|
2018
Q1 | $257K | Hold |
2,335
| – | – | ﹤0.01% | 1734 |
|
|
2017
Q4 | $292K | Sell |
2,335
-21
| -0.9% | -$2.66K | ﹤0.01% | 1641 |
|
|
2017
Q3 | $292K | Buy |
2,356
+77
| +3% | +$8.73K | ﹤0.01% | 2047 |
|
|
2017
Q2 | $233K | Sell |
2,279
-66
| -3% | -$6.52K | ﹤0.01% | 2241 |
|
|
2017
Q1 | $230K | Hold |
2,345
| – | – | ﹤0.01% | 2177 |
|
|
2016
Q4 | $188K | Sell |
2,345
-106
| -4% | -$7.96K | ﹤0.01% | 2383 |
|
|
2016
Q3 | $176K | Sell |
2,451
-117
| -5% | -$8.18K | ﹤0.01% | 2416 |
|
|
2016
Q2 | $169K | Sell |
2,568
-463
| -15% | -$34.6K | ﹤0.01% | 2438 |
|
|
2016
Q1 | $241K | Hold |
3,031
| – | – | ﹤0.01% | 2063 |
|
|
2015
Q4 | $347K | Buy |
3,031
+82
| +3% | +$9.28K | ﹤0.01% | 1875 |
|
|
2015
Q3 | $299K | Sell |
2,949
-307
| -9% | -$30.9K | ﹤0.01% | 1988 |
|
|
2015
Q2 | $342K | Buy |
3,256
+1,922
| +144% | +$202K | ﹤0.01% | 2028 |
|
|
2015
Q1 | $129K | Hold |
1,334
| – | – | ﹤0.01% | 2162 |
|
|
2014
Q4 | $143K | Hold |
1,334
| – | – | ﹤0.01% | 2555 |
|
|
2014
Q3 | $130K | Sell |
1,334
-96
| -7% | -$9.61K | ﹤0.01% | 2577 |
|
|
2014
Q2 | $139K | Sell |
1,430
-1,993
| -58% | -$181K | ﹤0.01% | 2659 |
|
|
2014
Q1 | $303K | Hold |
3,423
| – | – | ﹤0.01% | 2162 |
|
|
2013
Q4 | $280K | Hold |
3,423
| – | – | ﹤0.01% | 2226 |
|
|
2013
Q3 | $259K | Sell |
3,423
-46
| -1% | -$3.2K | ﹤0.01% | 2225 |
|
|
2013
Q2 | $219K | Buy |
+3,469
| New | +$210K | ﹤0.01% | 2293 |
|
Other funds holding VC
Metropolitan Life Insurance Company (MetLife)'s VC Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Visteon (VC) in Q2 2024, closing a stake of 1,449 shares — an estimated $170K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in VC in Q2 2013 and held it in 44 quarters. The position peaked at $1.52M in Q2 2021. 305 funds tracked by Wall St. Rank hold VC as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Visteon position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 1,449 Visteon shares in Q2 2024, an estimated $170K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Visteon in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Visteon position peaked at $1.52M in Q2 2021.
- 305 funds tracked by Wall St. Rank held Visteon as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.